What: Organovo Holdings, Inc. (Nasdaq:ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Keith Murphy, Chairman and CEO, will ring the Opening Bell. 

Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:Tuesday, October 18, 2016 – 9:15 a.m. to 9:30 a.m. ET  

Organovo Media Contacts:Steve Kunszabo(858) 224-1092skunszabo@organovo.com 

Peggy Vorwaldpeggy@litldog.com619-786-0353  

Nasdaq MarketSite:Emily Pan(646) 441-5120emily.pan@nasdaq.com  

Feed Information:Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page:  http://instagram.com/nasdaq 

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live 

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq 

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/  

Webcast:A live stream of the Nasdaq Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx  

Photos: To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.  

About Organovo Holdings, Inc. Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications.  The Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners.  Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.  The Company’s ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing.  The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications.  In addition to numerous scientific publications, the Company’s technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets.  Organovo is changing the shape of life science research and transforming medical care.  Learn more at www.organovo.com.  

About NasdaqNasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Organovo Charts.
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Organovo Charts.